An Arntl2-Driven Secretome Enables Lung Adenocarcinoma Metastatic Self-Sufficiency

Cancer Cell

Volumn 29, Issue 5, 2016, Pages 697-710

  Brady, Jennifer J ^a   Chuang, Chen Hua ^a   Greenside, Peyton G ^a   Rogers, Zoë N ^a   Murray, Christopher W ^a   Caswell, Deborah R ^a   Hartmann, Ursula ^d   Connolly, Andrew J ^a   Sweet Cordero, E Alejandro ^a,b   Kundaje, Anshul ^a,c   Winslow, Monte M ^a,b  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b STANFORD CANCER INSTITUTE   (United States)

^c Stanford University   (United States)

^d UNIVERSITY OF COLOGNE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN; PROTEIN SMOC2; PROTEOME; SECRETOME; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR ARNTL2; TRANSCRIPTION FACTOR CLOCK; UNCLASSIFIED DRUG; ARNTL2 PROTEIN, HUMAN; CALCIUM BINDING PROTEIN; SMOC2 PROTEIN, HUMAN; TRANSCRIPTION FACTOR ARNTL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANOIKIS; ARTICLE; CANCER CELL; CANCER PATIENT; CANCER SURVIVAL; CELL GROWTH; CLONOGENESIS; CONTROLLED STUDY; DISTANT METASTASIS; GENE EXPRESSION PROFILING; HUMAN; HUMAN CELL; HUMAN TISSUE; LUNG ADENOCARCINOMA; LYMPH NODE METASTASIS; MALE; METASTASIS; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; OUTCOME ASSESSMENT; PLEURA METASTASIS; PREDICTIVE VALUE; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN SECRETION; UPREGULATION; 129 MOUSE; ADENOCARCINOMA; ANIMAL; CELL PROLIFERATION; GENE EXPRESSION REGULATION; GENETICS; KNOCKOUT MOUSE; LUNG TUMOR; NONOBESE DIABETIC MOUSE; PATHOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA INTERFERENCE; SCID MOUSE; SECRETION (PROCESS); SURVIVAL ANALYSIS; TUMOR CELL LINE; WESTERN BLOTTING;

ADENOCARCINOMA; ANIMALS; ARNTL TRANSCRIPTION FACTORS; BLOTTING, WESTERN; CALCIUM-BINDING PROTEINS; CELL LINE, TUMOR; CELL PROLIFERATION; CLOCK PROTEINS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LUNG NEOPLASMS; MICE, 129 STRAIN; MICE, INBRED NOD; MICE, KNOCKOUT; MICE, SCID; NEOPLASM METASTASIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA INTERFERENCE; SURVIVAL ANALYSIS;

EID: 84963558365     PISSN: 15356108     EISSN: 18783686     Source Type: Journal    
DOI: 10.1016/j.ccell.2016.03.003     Document Type: Article

References (49)

1. Aceto N., Bardia A., Miyamoto D.T., Donaldson M.C., Wittner B.S., Spencer J.A., Yu M., Pely A., Engstrom A., Zhu H., et al. Circulating tumor cell clusters are oligoclonal precursors of breast cancer metastasis. Cell 2014, 158:1110-1122.
2. Bafico A., Liu G., Goldin L., Harris V., Aaronson S.A. An autocrine mechanism for constitutive Wnt pathway activation in human cancer cells. Cancer Cell 2004, 6:497-506.
3. Blanco M.A., LeRoy G., Khan Z., Alečković M., Zee B.M., Garcia B.A., Kang Y. Global secretome analysis identifies novel mediators of bone metastasis. Cell Res. 2012, 22:1339-1355.
4. Bo H., Zhang S., Gao L., Chen Y., Zhang J., Chang X., Zhu M. Upregulation of Wnt5a promotes epithelial-to-mesenchymal transition and metastasis of pancreatic cancer cells. BMC Cancer 2013, 13:496.
5. Bunger M.K., Wilsbacher L.D., Moran S.M., Clendenin C., Radcliffe L.A., Hogenesch J.B., Simon M.C., Takahashi J.S., Bradfield C.A. Mop3 is an essential component of the master circadian pacemaker in mammals. Cell 2000, 103:1009-1017.
6. Caswell D.R., Chuang C.-H., Yang D., Chiou S.-H., Cheemalavagu S., Kim-Kiselak C., Connolly A., Winslow M.M. Obligate progression precedes lung adenocarcinoma dissemination. Cancer Discov. 2014, 4:781-789.
7. Cheung W.K.C., Nguyen D.X. Lineage factors and differentiation states in lung cancer progression. Oncogene 2015, 34:5771-5780.
8. Cheung W.K.C., Zhao M., Liu Z., Stevens L.E., Cao P.D., Fang J.E., Westbrook T.F., Nguyen D.X. Control of alveolar differentiation by the lineage transcription factors GATA6 and HOPX inhibits lung adenocarcinoma metastasis. Cancer Cell 2013, 23:725-738.
9. Cox T.R., Rumney R.M.H., Schoof E.M., Perryman L., Høye A.M., Agrawal A., Bird D., Latif N.A., Forrest H., Evans H.R., et al. The hypoxic cancer secretome induces pre-metastatic bone lesions through lysyl oxidase. Nature 2015, 522:106-110.
10. De S., Chen J., Narizhneva N.V., Heston W., Brainard J., Sage E.H., Byzova T.V. Molecular pathway for cancer metastasis to bone. J. Biol. Chem. 2003, 278:39044-39050.
11. Desgrosellier J.S., Cheresh D.A. Integrins in cancer: biological implications and therapeutic opportunities. Nat. Rev. Cancer 2010, 10:9-22.
12. Ell B., Kang Y. Transcriptional control of cancer metastasis. Trends Cell Biol. 2013, 23:603-611.
13. Fidler I.J. The pathogenesis of cancer metastasis: the "seed and soil" hypothesis revisited. Nat. Rev. Cancer 2003, 3:453-458.
14. Györffy B., Surowiak P., Budczies J., Lánczky A. Online survival analysis software to assess the prognostic value of biomarkers using transcriptomic data in non-small-cell lung cancer. PLoS One 2013, 8:e82241.
15. Hanaki H., Yamamoto H., Sakane H., Matsumoto S., Ohdan H., Sato A., Kikuchi A. An anti-Wnt5a antibody suppresses metastasis of gastric cancer cells in vivo by inhibiting receptor-mediated endocytosis. Mol. Cancer Ther. 2012, 11:298-307.
16. Hogenesch J.B., Gu Y.-Z., Moran S.M., Shimomura K., Radcliffe L.A., Takahashi J.S., Bradfield C.A. The basic helix-loop-helix-PAS protein MOP9 is a brain-specific heterodimeric partner of circadian and hypoxia factors. J. Neurosci. 2000, 20:RC83.
17. Jackson E.L., Olive K.P., Tuveson D.A., Bronson R., Crowley D., Brown M., Jacks T. The differential effects of mutant p53 alleles on advanced murine lung cancer. Cancer Res. 2005, 65:10280-10288.
18. Kang Y., Siegel P.M., Shu W., Drobnjak M., Kakonen S.M., Cordón-Cardo C., Guise T.A., Massagué J. A multigenic program mediating breast cancer metastasis to bone. Cancer Cell 2003, 3:537-549.
19. Kimura S., Hara Y., Pineau T., Fernandez-Salguero P., Fox C.H., Ward J.M., Gonzalez F.J. The T/ebp null mouse: thyroid-specific enhancer-binding protein is essential for the organogenesis of the thyroid, lung, ventral forebrain, and pituitary. Genes Dev. 1996, 10:60-69.
20. Korpal M., Ell B.J., Buffa F.M., Ibrahim T., Blanco M.A., Celià-Terrassa T., Mercatali L., Khan Z., Goodarzi H., Hua Y., et al. Direct targeting of Sec23a by miR-200s influences cancer cell secretome and promotes metastatic colonization. Nat. Med. 2011, 17:1101-1108.
21. Li C.M.-C., Chen G., Dayton T.L., Kim-Kiselak C., Hoersch S., Whittaker C.A., Bronson R.T., Beer D.G., Winslow M.M., Jacks T. Differential Tks5 isoform expression contributes to metastatic invasion of lung adenocarcinoma. Genes Dev. 2013, 27:1557-1567.
22. Li X., Xu Z., Du W., Zhang Z., Wei Y., Wang H., Zhu Z., Qin L., Wang L., Niu Q., et al. Aiolos promotes anchorage independence by silencing p66Shc transcription in cancer cells. Cancer Cell 2014, 25:575-589.
23. Li C.M.C., Gocheva V., Oudin M.J., Bhutkar A., Wang S.Y., Date S.R., Ng S.R., Whittaker C.A., Bronson R.T., Snyder E.L., Gertler F.B. Foxa2 and Cdx2 cooperate with Nkx2-1 to inhibit lung adenocarcinoma metastasis. Genes Dev. 2015, 29:1850-1862.
24. Lu Z., Ghosh S., Wang Z., Hunter T. Downregulation of caveolin-1 function by EGF leads to the loss of E-cadherin, increased transcriptional activity of beta-catenin, and enhanced tumor cell invasion. Cancer Cell 2003, 4:499-515.
25. Maier S., Paulsson M., Hartmann U. The widely expressed extracellular matrix protein SMOC-2 promotes keratinocyte attachment and migration. Exp. Cell Res. 2008, 314:2477-2487.
26. Mazzoccoli G., Pazienza V., Panza A., Valvano M.R., Benegiamo G., Vinciguerra M., Andriulli A., Piepoli A. ARNTL2 and SERPINE1: potential biomarkers for tumor aggressiveness in colorectal cancer. J. Cancer Res. Clin. Oncol. 2012, 138:501-511.
27. McAllister S.S., Weinberg R.A. The tumour-induced systemic environment as a critical regulator of cancer progression and metastasis. Nat. Cell Biol. 2014, 16:717-727.
28. Mo W., Chen J., Patel A., Zhang L., Chau V., Li Y., Cho W., Lim K., Xu J., Lazar A.J., et al. CXCR4/CXCL12 mediate autocrine cell- cycle progression in NF1-associated malignant peripheral nerve sheath tumors. Cell 2013, 152:1077-1090.
29. Mommaerts H., Esguerra C.V., Hartmann U., Luyten F.P., Tylzanowski P. Smoc2 modulates embryonic myelopoiesis during zebrafish development. Dev. Dyn. 2014, 243:1375-1390.
30. Mu D. The complexity of thyroid transcription factor 1 with both pro- and anti-oncogenic activities. J. Biol. Chem. 2013, 288:24992-25000.
31. Murphy-Ullrich J.E., Sage E.H. Revisiting the matricellular concept. Matrix Biol. J. Int. Soc. Matrix Biol. 2014, 37:1-14.
32. Nguyen D.X., Bos P.D., Massagué J. Metastasis: from dissemination to organ-specific colonization. Nat. Rev. Cancer 2009, 9:274-284.
33. Nguyen D.X., Chiang A.C., Zhang X.H.-F., Kim J.Y., Kris M.G., Ladanyi M., Gerald W.L., Massagué J. WNT/TCF signaling through LEF1 and HOXB9 mediates lung adenocarcinoma metastasis. Cell 2009, 138:51-62.
34. Obenauf A.C., Zou Y., Ji A.L., Vanharanta S., Shu W., Shi H., Kong X., Bosenberg M.C., Wiesner T., Rosen N., et al. Therapy-induced tumour secretomes promote resistance and tumour progression. Nature 2015, 520:368-372.
35. Oskarsson T., Acharyya S., Zhang X.H.-F., Vanharanta S., Tavazoie S.F., Morris P.G., Downey R.J., Manova-Todorova K., Brogi E., Massagué J. Breast cancer cells produce tenascin C as a metastatic niche component to colonize the lungs. Nat. Med. 2011, 17:867-874.
36. Prowse A.B.J., Chong F., Gray P.P., Munro T.P. Stem cell integrins: implications for ex-vivo culture and cellular therapies. Stem Cell Res. 2011, 6:1-12.
37. Rocnik E.F., Liu P., Sato K., Walsh K., Vaziri C. The novel SPARC family member SMOC-2 potentiates angiogenic growth factor activity. J. Biol. Chem. 2006, 281:22855-22864.
38. Sage H., Vernon R.B., Funk S.E., Everitt E.A., Angello J. SPARC, a secreted protein associated with cellular proliferation, inhibits cell spreading in vitro and exhibits Ca+2-dependent binding to the extracellular matrix. J. Cell Biol. 1989, 109:341-356.
39. Sasaki M., Yoshitane H., Du N.-H., Okano T., Fukada Y. Preferential inhibition of BMAL2-CLOCK activity by PER2 reemphasizes its negative role and a positive role of BMAL2 in the circadian transcription. J. Biol. Chem. 2009, 284:25149-25159.
40. Shedden K., Taylor J.M.G., Enkemann S.A., Tsao M.-S., Yeatman T.J., Gerald W.L., Eschrich S., Jurisica I., Giordano T.J., Misek D.E., et al. Gene expression-based survival prediction in lung adenocarcinoma: a multi-site, blinded validation study. Nat. Med. 2008, 14:822-827.
41. Shi S., Hida A., McGuinness O.P., Wasserman D.H., Yamazaki S., Johnson C.H. Circadian clock gene Bmal1 is not essential after all; functional replacement with its paralog, Bmal2. Curr. Biol. 2010, 20:316-321.
42. Shvab A., Haase G., Ben-Shmuel A., Gavert N., Brabletz T., Dedhar S., Ben-Ze'ev A. Induction of the intestinal stem cell signature gene SMOC-2 is required for L1-mediated colon cancer progression. Oncogene 2015, 35:549-557.
43. Siegel R.L., Miller K.D., Jemal A. Cancer statistics, 2016. CA. Cancer J. Clin. 2016, 66:7-30.
44. The Cancer Genome Atlas Research Network Comprehensive molecular profiling of lung adenocarcinoma. Nature 2014, 511:543-550.
45. Weeraratna A.T., Jiang Y., Hostetter G., Rosenblatt K., Duray P., Bittner M., Trent J.M. Wnt5a signaling directly affects cell motility and invasion of metastatic melanoma. Cancer Cell 2002, 1:279-288.
46. Wilson T.R., Lee D.Y., Berry L., Shames D.S., Settleman J. Neuregulin-1-mediated autocrine signaling underlies sensitivity to HER2 Kinase Inhibitors in a subset of human cancers. Cancer Cell 2011, 20:158-172.
47. Winslow M.M., Dayton T.L., Verhaak R.G.W., Kim-Kiselak C., Snyder E.L., Feldser D.M., Hubbard D.D., DuPage M.J., Whittaker C.A., Hoersch S., et al. Suppression of lung adenocarcinoma progression by Nkx2-1. Nature 2011, 473:101-104.
48. Zhou S.-L., Dai Z., Zhou Z.-J., Chen Q., Wang Z., Xiao Y.-S., Hu Z.-Q., Huang X.-Y., Yang G.-H., Shi Y.-H., et al. CXCL5 contributes to tumor metastasis and recurrence of intrahepatic cholangiocarcinoma by recruiting infiltrative intratumoral neutrophils. Carcinogenesis 2014, 35:597-605.
49. Zhu Z., Aref A.R., Cohoon T.J., Barbie T.U., Imamura Y., Yang S., Moody S.E., Shen R.R., Schinzel A.C., Thai T.C., et al. Inhibition of KRAS-driven tumorigenicity by interruption of an autocrine cytokine circuit. Cancer Discov. 2014, 4:452-465.